Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132820) titled 'Smart-tech empowerment for optimizing short-course chemotherapy plans for drug-sensitive tuberculosis in the elderly and a multicenter randomized controlled clinical study (Project 5: Clinical study of short-course treatment regimens for drug-sensitive tuberculosis in the elderly)' on Sept. 18.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Public Health Clinical Center
Condition:
tuberculosis
Intervention:
A group(Ultra-short):2-3 months including BSLZ plan
C group (Control):Standard adult chemotherapy regimen 2HREZ/4-6HR
Recruitment Status: Not Recruiting
Phase: 4 ...